Key facts
- This page summarizes Roger Adsett's Form 4 filing for INSMED Inc (INSM).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Feb 2025, 16:45.
Roger Adsett - 10 Feb 2025 Form 4 Insider Report for INSMED Inc (INSM)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- INSM
- Reported as of
- 10 Feb 2025
- Net transaction value
- -$3,378,067
- SEC form
- 4
- Accepted by SEC
- 12 Feb 2025, 16:45:44 UTC
- Prior SEC filing
- 07 Feb 2025
- Next SEC filing
- 15 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Roger Adsett, by Michael A. Smith as Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Roger Adsett filed Form 4 for INSMED Inc (INSM) on 12 Feb 2025.
Change
- Previous filing in this sequence was filed on 07 Feb 2025.
- Current net transaction value: -$3,378,067.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INSM
transaction
Common Stock
Sale
- Transaction value
- $851,302
- Shares
- -11,053
- Change %
- -5.8%
- Price
- $77.02
- Shares after
- 178,004
- Date
- 10 Feb 2025
- Ownership
- Direct
- Footnotes
- F1, F2
INSM
transaction
Common Stock
Sale
- Transaction value
- $452,999
- Shares
- -5,781
- Change %
- -3.2%
- Price
- $78.36
- Shares after
- 172,223
- Date
- 10 Feb 2025
- Ownership
- Direct
- Footnotes
- F1, F3
INSM
transaction
Common Stock
Sale
- Transaction value
- $2,073,766
- Shares
- -26,141
- Change %
- -15%
- Price
- $79.33
- Shares after
- 146,082
- Date
- 10 Feb 2025
- Ownership
- Direct
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 4 footnotes
Footnote F1
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Footnote F2
This is the weighted average sales price representing 11,053 shares sold at prices ranging from $76.74 to $77.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F3
This is the weighted average sales price representing 5,781 shares sold at prices ranging from $78.10 to $78.59 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F4
This is the weighted average sales price representing 26,141 shares sold at prices ranging from $78.61 to $79.54 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.